Transgene News and Research

RSS
Phase I/II study shows safety and efficacy of VB-111 in patients with rGBM

Phase I/II study shows safety and efficacy of VB-111 in patients with rGBM

ElsaLys Biotech announces first round of financing from Transgene and Sofimac Partners

ElsaLys Biotech announces first round of financing from Transgene and Sofimac Partners

Transgene announces pre-clinical data of TG1050 for treatment of chronic hepatitis B infection

Transgene announces pre-clinical data of TG1050 for treatment of chronic hepatitis B infection

Animal models of Huntington's disease allow better insights into disease's genetics

Animal models of Huntington's disease allow better insights into disease's genetics

Clinical data of two Transgene products to be presented at EASL Conference

Clinical data of two Transgene products to be presented at EASL Conference

GenSight Biologics announces closing of €32 million Series A financing

GenSight Biologics announces closing of €32 million Series A financing

Researchers study influence of muscle types, body metabolism in diabetes

Researchers study influence of muscle types, body metabolism in diabetes

Research: Specific gene action during exposure to adolescent trauma is critical for development of PTSD

Research: Specific gene action during exposure to adolescent trauma is critical for development of PTSD

Researchers identify vulnerability of lung-cancer cells that can be exploited for new therapies

Researchers identify vulnerability of lung-cancer cells that can be exploited for new therapies

Max Planck Florida Institute for Neuroscience gets grant for research into neurological disorders

Max Planck Florida Institute for Neuroscience gets grant for research into neurological disorders

ALN RNAi therapeutic program represents novel approach for treatment of AAT deficiency

ALN RNAi therapeutic program represents novel approach for treatment of AAT deficiency

SAGE Labs, Autism Speaks expand partnership to create first rat models for translational research

SAGE Labs, Autism Speaks expand partnership to create first rat models for translational research

Targeted delivery of therapeutic gene can effectively treat Pompe disease

Targeted delivery of therapeutic gene can effectively treat Pompe disease

Adeona to develop and commercialize DNA-based therapeutic for PAH using Intrexon technology

Adeona to develop and commercialize DNA-based therapeutic for PAH using Intrexon technology

Jennerex commences enrollment in JX-594 Phase 2b trial for HCC

Jennerex commences enrollment in JX-594 Phase 2b trial for HCC

VGX International, Inovio partner to co-develop SynCon vaccines for hepatitis B and C infections

VGX International, Inovio partner to co-develop SynCon vaccines for hepatitis B and C infections

Caffeine in sunscreens may protect from skin cancer: Study

Caffeine in sunscreens may protect from skin cancer: Study

Insect virus holds key to safer stem cell therapy: Singapore scientists

Insect virus holds key to safer stem cell therapy: Singapore scientists

Sigma introduces CompoZr Targeted Integration Kit – mRosa26

Sigma introduces CompoZr Targeted Integration Kit – mRosa26

Adamis receives European patent for novel cell-based cancer vaccine technology

Adamis receives European patent for novel cell-based cancer vaccine technology